VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
APMAptorum Group Limited
$0.77$5M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksAPMCash Flow

Aptorum Group Limited (APM) Cash Flow Statement

9Y historyFree accessUpdated daily

Free cash flow remains structurally negative, with the company's inability to generate operational liquidity underscored by an erratic OCF/NI ratio that frequently deviates from sustainable performance metrics.

APM Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17
Cash from Operations-8.97M-1.84M-1.19M-7.72M-12.32M-14.65M-15.93M-13.38M-10.04M-5.78M
Operating CF Margin %----1790.63%-950.54%-950.17%-1747.86%-2500.65%-2617.17%-
Operating CF Growth %265.43%-54.14%84.58%37.3%15.92%8.04%-19.05%-33.35%-73.54%-
Net Income-7.09M-1.36M-4.27M-4.34M-11.53M-27.11M4.92M-20.12M-15.13M-2.55M
Depreciation & Amortization1.38M0255.05K1.13M1.21M1.19M1.33M1.3M682.29K58.9K
Stock-Based Compensation0001.27M1.65M1.68M1.48M1.61M00
Deferred Taxes000007.96M-24.46M-1.53M00
Other Non-Cash Items-2.14M-369.97K3.03M-6.18M-5.05M609.34K751.03K4.14M4.81M-2.93M
Working Capital Changes195.96K-102.84K-211.1K407.07K1.4M1.02M45.55K1.22M-389.73K-195.09K
Change in Receivables168.72K17.51K41.35K417.22K-171.91K-16.5K-21.68K-37.72K-2.83K-48.01K
Change in Inventory14.52K0014.52K8.05K3.36K-4.95K-3.54K-30.64K0
Change in Payables0-28.37K0398.63K1.92M855.27K800.96K986.24K58.55K0
Cash from Investing683.39K058.62K624.77K2.44M16.51M1.84M-108.06K-6.06M12.8M
Capital Expenditures-2.98K00-3.02K-186.92K-137.78K-161.31K-1.11M-6.06M-3.06M
CapEx % of Revenue0.69%--0.7%14.42%8.93%17.7%206.88%1581.51%-
Acquisitions74.01K058.62K15.38K0-113.83K25.24M270.11K417.79K0
Investments----------
Other Investing519.14K00519.18K2.5M-3.35M1.05M-70.11K83.73K-186.9K
Cash from Financing4.15M4.41M1.43K4.09M6.63M2.78M12.42M-7.32M25.48M9.08M
Debt Issued (Net)2.56M-4641.43K2.55M6.45M-2.04M-4.36M-7.32M16.06M480K
Equity Issued (Net)1.59M4.42M01.59M5.36K4M17.5M011.05M8.6M
Dividends Paid000000-755.51K000
Share Repurchases0000000000
Other Financing000-54.53K169.46K824.24K40.42K0-1.64M0
Net Change in Cash-4.14M2.58M-1.13M-3.01M-3.25M4.64M-1.67M-20.81M9.38M16.1M
Free Cash Flow-8.97M-1.84M-1.19M-7.73M-12.51M-14.79M-16.09M-14.49M-16.1M-8.84M
FCF Margin %-2080.09%---1791.32%-964.96%-959.11%-1765.56%-2707.53%-4198.68%-
FCF Growth %66.88%-54.14%84.59%38.21%15.44%8.1%-11.07%10%-82.08%-
FCF per Share-1.60-0.25-0.22-1.71-3.50-4.22-5.10-4.99-5.77-2.94
FCF Conversion (FCF/Net Income)1.27x1.35x0.28x2.73x1.26x0.58x-2.25x0.72x0.68x2.27x
Interest Paid0000000000
Taxes Paid0000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Insufficient capital runway

Earnings Quality Lacks Cash Support

According to historical financial data, the relationship between net income and operating cash flow is highly erratic, with the OCF/NI ratio frequently swinging between positive and negative values, suggesting that reported earnings are largely disconnected from the company's actual ability to generate sustainable operational liquidity.

The extreme volatility in the OCF/NI ratio indicates that net income is heavily influenced by non-cash items or accounting adjustments rather than core operational performance. Investors should interpret this divergence as a signal that the company's reported profitability metrics are not reliable indicators of its underlying cash-generating capacity.

Persistent Free Cash Flow Deficits

As reported in recent financial statements, Aptorum's free cash flow trajectory remains consistently negative, reflecting a structural reliance on external financing to fund its R&D pipeline, with the most recent quarterly figures showing a marginal cash inflow that appears to be an outlier rather than a trend.

The persistent inability to generate positive free cash flow highlights the company's high burn rate relative to its current development stage. This trajectory suggests that the firm remains entirely dependent on capital markets to sustain its clinical operations, which warrants significant caution regarding future dilution.

Working Capital Volatility Masks Burn

Based on reported figures, working capital changes have been highly inconsistent, with swings as large as $912.5K in 2023Q4, indicating that the company's cash position is frequently impacted by timing differences in payables and receivables rather than stable operational efficiency or consistent cash conversion cycles.

The erratic nature of working capital adjustments suggests that management may be attempting to manage liquidity through the timing of payments, which is a common but unsustainable practice for firms with limited cash reserves. This volatility obscures the true underlying cash burn rate and complicates the assessment of operational health.

Capital Allocation Remains Highly Dilutive

As evidenced by historical cash flow statements, the company has prioritized share repurchases and other capital outflows despite persistent operating losses, a strategy that appears to have exacerbated the depletion of cash reserves and necessitated further reliance on equity financing to maintain the current clinical pipeline.

The decision to allocate capital toward share buybacks while simultaneously burning cash to fund R&D suggests a misalignment between capital deployment and the company's actual financial position. This approach may indicate that management has historically prioritized short-term market optics over the long-term preservation of the balance sheet.

APM — Frequently Asked Questions

Quick answers to the most common questions about buying APM stock.

How much cash does Aptorum Group Limited (APM) generate from operations?

Aptorum Group Limited (APM) generated $-1.8M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Aptorum Group Limited's free cash flow?

Aptorum Group Limited (APM) reported negative free cash flow of $1.8M in 2025, indicating capital requirements exceeded cash from operations.

What is Aptorum Group Limited's capital expenditure (CapEx)?

Aptorum Group Limited (APM) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.